| Authors: |
Pfirschke C; Division of Translational Immunology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Gebhardt C; Skin Cancer Unit, DKFZ, Heidelberg, Germany.; Department of Dermatology, Ruperto-Carola University of Heidelberg, Heidelberg, Germany.; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruperto-Carola University of Heidelberg, Mannheim, Germany., Zörnig I; Department of Medical Oncology, NCT, Heidelberg University Hospital, Heidelberg, Germany., Pritsch M; Division of Translational Immunology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Eichmüller SB; Division of Translational Immunology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Jäger D; Department of Medical Oncology, NCT, Heidelberg University Hospital, Heidelberg, Germany., Enk A; Department of Dermatology, Ruperto-Carola University of Heidelberg, Heidelberg, Germany., Beckhove P; Division of Translational Immunology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany. Philipp.Beckhove@klinik.uni-regensburg.de.; Regensburg Center for Interventional Immunology (RCI), University of Regensburg, Regensburg, Germany. Philipp.Beckhove@klinik.uni-regensburg.de.; University Clinic of Regensburg, Franz-Josef-Strauß-Allee 11, 93053, Regensburg, Germany. Philipp.Beckhove@klinik.uni-regensburg.de. |